tiprankstipranks
NeuroMetrix reports Q3 revenue $587,314 vs $1.2M last year
PremiumThe FlyNeuroMetrix reports Q3 revenue $587,314 vs $1.2M last year
2M ago
NeuroMetrix says opportunities reviewed not in best interest at this time
Premium
The Fly
NeuroMetrix says opportunities reviewed not in best interest at this time
4M ago
NeuroMetrix reports Q2 EPS (74c) vs. ($1.56) last year
Premium
The Fly
NeuroMetrix reports Q2 EPS (74c) vs. ($1.56) last year
5M ago
NeuroMetrix appoints Joshua Horowitz to board, terminates ATM equity facility
PremiumThe FlyNeuroMetrix appoints Joshua Horowitz to board, terminates ATM equity facility
8M ago
NeuroMetrix announces publication of study on DPNCheck
Premium
The Fly
NeuroMetrix announces publication of study on DPNCheck
9M ago
NeuroMetrix reports over 2000 patients prescribed Quell Fibromyalgia
Premium
The Fly
NeuroMetrix reports over 2000 patients prescribed Quell Fibromyalgia
9M ago
NeuroMetrix reports results from pilot trial of Quell in post-acute covid-19
PremiumThe FlyNeuroMetrix reports results from pilot trial of Quell in post-acute covid-19
1y ago
NeuroMetrix announces publication of Phase 2 trial data on Quell
Premium
The Fly
NeuroMetrix announces publication of Phase 2 trial data on Quell
1y ago
NeuroMetrix trading halted, news pending
Premium
The Fly
NeuroMetrix trading halted, news pending
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100